IP Verse

Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof

Patent No. EP3458083 (titled "Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof") was filed by Moderna on May 18, 2017. The application was issued on Nov 2, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIONTECHAug 2, 2023THOMANN
BARKER BRETTELLAug 1, 2023BARKER BRETTELL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3458083

MODERNA
Application Number
EP17726458A
Filing Date
May 18, 2017
Status
Revoked
May 17, 2024
Publication Date
Nov 2, 2022
External Links
Slate, EP3458083B1, Google Patents